Loading market dashboard

Estimates, scoring, valuation assumptions, and peer comparison in one research surface.
IO Biotech, Inc. · Forecast overview
Bars show expected revenue while the line tracks expected EPS.
| Period | Revenue avg | Revenue range | EBITDA | EPS avg | Analysts |
|---|---|---|---|---|---|
| Dec 2030 | $212.23M | $212.23M - $212.23M | $0.00 | -$0.04 | 1 |
| Dec 2029 | $145.87M | $145.87M - $145.87M | $0.00 | -$0.04 | 1 |
| Dec 2028 | $54.10M | $54.10M - $54.10M | $0.00 | -$0.19 | 2 |
| Dec 2027 | $17.83M | $17.83M - $17.83M | $0.00 | -$0.313 | 2 |
| Dec 2026 | $13.87M | $13.87M - $13.87M | $0.00 | -$0.29 | 2 |
| Dec 2025 | $940.0K | $940.0K - $940.0K | $0.00 | -$1.013 | 2 |
| Dec 2024 | $0.00 | $0.00 - $0.00 | $0.00 | -$1.36 | 0 |